HomePage - Macleods

Research & Development

Integral to our operations, are our R&D and bioequivalence centres. Our comprehensive R&D facility comprises of scientists and staff, who focus on the development of active pharmaceutical ingredients (APIs) and formulations, analytical development and bioequivalence studies. With 250 beds, this bioequivalence centre supports to conduct in-house bio equivalence studies.

Manufacturing

We take pride in our robust manufacturing operations and quality standards. We strive to meet these by focusing on achieving the highest benchmarks of hygiene, cleanliness and eliminating cross-contamination. Our manufacturing facilities are equipped to meet the mandatory prerequisites of Indian and various international regulatory bodies.

An eye for uncompromising quality

INDIA

USA

ETHIOPIA

EUROPE

IVORY COAST

MALAYSIA

ZIMBABWE

SOUTH AFRICA

UGANDA

SAUDI ARABIA

SOUTH AFRICA

UKRAINE

WHO GENEVA

KENYA

Clinical

Spread across 27,400 sq. ft, in Mumbai and Ahmedabad.
Supported by a NABL accredited clinical lab that has advanced machines such as Dimension EXL 200 (biochemistry), Sysmex XN 550 (haematology) and a LIS system to record, manage and store lab data.
Subject registrations carried out, using biometrics
Subject screening carried out to ensure stringent compliances (staging, height/ weight and volunteer registration, doctors’ room, ECG and X-ray).
Dosing and phlebotomy area available.

Pharmacy with controlled condition storage available.
Comprises of clinical pharmacological unit (CPU), with 248 beds.
Sample separation and storage room available, with a capacity for 48,000+ samples.
Round-the-clock monitoring is carried out by qualified doctors.
Contains a fully-equipped ICU.

Bioanalytical

Spread across 7700 sq. ft.
Facilitates method development and validation from human matrices (blood, serum, plasma and urine).
Has carried out 400+ validated methods.
Equipped for investigative procedures for low detection, chiral assays, light sensitivity, unstable molecules and conjugated and unconjugated assays.
Studies on invitro equilibrium phosphate and bile salts binding carried out.

Facilitates invitro release test (IVRT) and invitro permeation test (IVPT) on cadaver skin.
Comprises of a laboratory outfitted with 20 LC/MS/MS highly sensitive equipment.
Facility for controlled sample storage with a capacity for 32,000+ samples available.
Equipped with 21 CFR-compliant software (Analyst/ Chromleon/ Diffusion Master)

Pharmacokinetic and statistical

This is a SAS-powered statistical analysis software unit.
Enables two/ three/ four-way crossover BE studies as well as replicate crossover studies.
Facilitates parallel BE studies and steady-state BE studies.
Facilitates Invitro studies.
Facilitates Skin blanching studies.

Quality Assurance

Strictly adheres to GCP, GLP and regulatory requirements through online and retrospective audits.
Carries out in-house system and facility audits and outsourced services.
Has SOPs to ensure the uniformity of procedures, across the clinical, analytical and statistical sections.

Data Protection

Controlled access available, to ensure data confidentiality and integrity.
Dedicated servers available for software and laboratory data.
Separate archiving area for the documentation resulting from the QA procedures available.

Quality & Accessible
Medicines for All

Achieving new milestones everyday

Research & Development

Manufacturing

Our global footprint

An eye for uncompromising quality

Key divisions

Clinical

Bioanalytical

Pharmacokinetic and statistical

Quality Assurance

Data Protection

Quality & AccessibleMedicines for All

Achieving new milestones everyday

Research & Development

Manufacturing

Our global footprint

An eye for uncompromising quality

Quality & Accessible
Medicines for All